PTIX
Protagenic
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 0
Sell signal 1
Downward Gap
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About PTIX
Protagenic Therapeutics, Inc.
A biopharmaceutical company that developing therapeutics to treat stress-related neuropsychiatric and mood disorders
149 Fifth Avenue, New York, New York, 10010
--
Protagenic Therapeutics, Inc., is incorporated in Delaware. The Company is a biopharmaceutical company specializing in the discovery and development of therapies for the treatment of stress-related neuropsychiatric and mood disorders.
Company Financials
EPS
PTIX has released its 2023 Q3 earnings. EPS was reported at -0.32, versus the expected 0.00, missing expectations. The chart below visualizes how PTIX has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
